← All companies

SVA

Sinovac Biotech Ltd.

SVA Nasdaq Pharmaceutical Preparations EDGAR ↗

$6.47

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$465M

Revenue (TTM)

$386M

Net income (TTM)

-$199M

EPS (TTM)

$-0.83

P/E ratio

—

Dividend yield

850.08%

Free cash flow

-$561M

Cash

$488M

Total assets

$8.54B

Gross margin

67.9%

52-week range

$6.47 – $6.47

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 15, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jun 15, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jun 5, 2026 20-F Jun 5, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER May 29, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER May 21, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER May 8, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER May 7, 2026 20-F Apr 30, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 22, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Jan 5, 2026 6-K REPORT OF FOREIGN PRIVATE ISSUER Dec 17, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Nov 20, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Nov 5, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Aug 21, 2025 6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 11, 2025 6-K FORM 6-K Jul 10, 2025 6-K FORM 6-K Jul 10, 2025 6-K FORM 6-K Jul 8, 2025 6-K FORM 6-K Jul 2, 2025 6-K FORM 6-K Jun 30, 2025 6-K FORM 6-K Jun 25, 2025 6-K FORM 6-K Jun 20, 2025 6-K FORM 6-K Jun 18, 2025 6-K FORM 6-K Jun 18, 2025 6-K FORM 6-K May 23, 2025 6-K FORM 6-K May 20, 2025 6-K FORM 6-K May 19, 2025 6-K FORM 6-K Apr 30, 2025 6-K FORM 6-K Apr 21, 2025 6-K FORM 6-K Apr 1, 2025 6-K FORM 6-K Mar 31, 2025 6-K FORM 6-K Feb 28, 2025 6-K FORM 6-K Jan 16, 2025 6-K FORM 6-K Aug 16, 2024 6-K FORM 6-K Apr 30, 2024 20-F Apr 29, 2024 6-K FORM 6-K Feb 21, 2024 6-K FORM 6-K Sep 11, 2023 6-K FORM 6-K Aug 29, 2023